Immune cell topography of head and neck cancer

被引:3
|
作者
Muijlwijk, Tara [1 ,2 ,3 ]
Nijenhuis, Dennis N. L. M. [1 ,2 ,3 ]
Ganzevles, Sonja H. [1 ,2 ,3 ]
Ekhlas, Fatima [1 ,2 ,3 ]
Ballesteros-Merino, Carmen [4 ]
Peferoen, Laura A. N. [2 ,5 ,6 ]
Bloemena, Elisabeth [2 ,5 ,6 ]
Fox, Bernard A. [4 ]
Poell, Jos B. [1 ,2 ]
Leemans, C. Rene [1 ,2 ]
Brakenhoff, Ruud H. [1 ,2 ]
van de Ven, Rieneke [1 ,2 ,3 ]
机构
[1] Amsterdam UMC Locatie VUmc, Otolaryngol Head & Neck Surg, Amsterdam, Netherlands
[2] Canc Ctr Amsterdam, Canc Biol & Immunol, Amsterdam, Netherlands
[3] Amsterdam Inst Immunol & Infect Dis, Canc Immunol, Amsterdam, Netherlands
[4] Earle A Chiles Res Inst, Providence Canc Ctr, Robert W Franz Canc Res Ctr, Mol & Tumor Immunol Lab, Portland, OR USA
[5] Amsterdam UMC Locatie VUMC, Pathol, Amsterdam, Netherlands
[6] Acad Ctr Dent Amsterdam, Maxillofacial Surg Oral Pathol, Amsterdam, Netherlands
关键词
B cell; Head and Neck Cancer; Macrophage; T cell; Tumor microenvironment - TME; HUMAN-PAPILLOMAVIRUS; TUMOR; CARCINOMA; SURVIVAL; LARYNX; MICROENVIRONMENT; HYPOPHARYNX; HPV;
D O I
10.1136/jitc-2024-009550
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Approximately 50% of head and neck squamous cell carcinomas (HNSCC) recur after treatment with curative intent. Immune checkpoint inhibitors are treatment options for recurrent/metastatic HNSCC; however, less than 20% of patients respond. To increase this response rate, it is fundamental to increase our understanding of the spatial tumor immune microenvironment (TIME).Methods In total, 53 HNSCC specimens were included. Using a seven-color multiplex immunohistochemistry panel we identified tumor cells, CD163+macrophages, B cells, CD8+T cells, CD4+T helper cells and regulatory T cells (Tregs) in treatment-naive surgical resection specimens (n=29) and biopsies (n=18). To further characterize tumor-infiltrating CD8+T cells, we stained surgical resection specimens (n=12) with a five-color tumor-resident panel including CD103, Ki67, CD8 and pan-cytokeratin. Secretome analysis was performed on matched tumor suspensions (n=11) to measure protein levels.Results Based on CD8+T cell infiltrates, we identified four different immunotypes: fully infiltrated, stroma-restricted, immune-excluded, and immune-desert. We found higher cytokine levels in fully infiltrated tumors compared with other immunotypes. While the highest immune infiltrates were observed in the invasive margin for all immune cells, CD163+macrophages and Tregs had the highest tendency to infiltrate the tumor center. Within the tumor center, especially B cells stayed at the tumor stroma, whereas CD163+macrophages, followed by T cells, were more often localized within tumor fields. Also, B cells were found further away from other cells and often formed aggregates while T cells and CD163+macrophages tended to be more closely located to each other. Across resection specimens from various anatomical sites within the head and neck, oral cavity tumors exhibited the highest densities of Tregs. Moreover, the distance from B cells and T cells to tumor cells was shortest in oral cavity squamous cell carcinoma (OCSCC), suggesting more interaction between lymphocytes and tumor cells. Also, the fraction of T cells within 10 mu m of CD163+macrophages was lowest in OCSCC, indicating fewer myeloid/T-cell suppressive interactions in OCSCC.Conclusions We comprehensively described the TIME of HNSCC using a unique data set of resection specimens. We discovered that the composition, as well as the relative localization of immune cells in the TIME, differed in distinct anatomical sites of the head and neck.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Immune landscape in Head and Neck cancer
    Brandau, S.
    RADIOTHERAPY AND ONCOLOGY, 2019, 132 : 6 - 6
  • [2] Immune modulatory properties of head and neck cancer cell lines on different innate immune cell subtypes
    Wunderlich, R.
    Unger, K.
    Hess, J.
    Lauber, K.
    Frey, B.
    Gaipl, U.
    Zitzelsberger, H.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2016, 192 : 135 - 135
  • [3] Immune checkpoint expression in head and neck cancer
    Puntigam, L.
    Jeske, S.
    Brunner, C.
    Hoffmann, T.
    Schuler, P.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 96 - 97
  • [4] Immune Checkpoint Inhibition in Head and Neck Cancer
    Forster, Martin David
    Devlin, Michael-John
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [5] Importance of the immune system in head and neck cancer
    Mirza, Adal H.
    Thomas, Gareth
    Ottensmeier, Christian H.
    King, Emma V.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2019, 41 (08): : 2789 - 2800
  • [6] The immune landscape and immunotherapy for head and neck cancer
    Gregoire, V.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S120 - S120
  • [7] Targeting the immune system in head and neck cancer
    de Castro, Gilberto, Jr.
    Isaacsson Velho, Pedro H.
    CURRENT OPINION IN ONCOLOGY, 2015, 27 (03) : 157 - 158
  • [8] Exosomes as immune regulators in head and neck cancer
    Ludwig, S.
    Rotter, N.
    Theodoraki, M-N
    Jablonska, J.
    Lammert, A.
    Lang, S.
    HNO, 2020, 68 (10) : 719 - 725
  • [9] Head and neck squamous cell cancer
    Tryggvason, Geir
    Sveinsson, Porarinn E.
    Hjartarson, Hannes
    Halfdanarson, Porvarour R.
    LAEKNABLADID, 2009, 95 (10): : 671 - 680
  • [10] ATTRACTION OF IMMUNE CELLS BY HEAD AND NECK CANCER CELL LINES AND PRIMARY TUMORCONDITIONED SUPERNATANTS
    Muijlwijk, Tara
    Remkes, Naomi
    Poell, Jos
    Leemans, Rene
    Brakenhoff, Ruud
    van de Ven, Rieneke
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A981 - A981